Hogan, M. J. & Pardi, N. mRNA vaccines in the COVID-19 pandemic and beyond. Annu. Rev. Med. 73, 17–39 (2022).
Article CAS PubMed Google Scholar
Zhang, Y. et al. The biogenesis of nascent circular RNAs. Cell Rep. 15, 611–624 (2016).
Article CAS PubMed Google Scholar
Enuka, Y. et al. Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor. Nucleic Acids Res. 44, 1370–1383 (2016).
Article CAS PubMed Google Scholar
Sanger, H. L., Klotz, G., Riesner, D., Gross, H. J. & Kleinschmidt, A. K. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc. Natl Acad. Sci. USA 73, 3852–3856 (1976).
Article CAS PubMed PubMed Central Google Scholar
Nigro, J. M. et al. Scrambled exons. Cell 64, 607–613 (1991).
Article CAS PubMed Google Scholar
Kristensen, L. S. et al. The biogenesis, biology and characterization of circular RNAs. Nat. Rev. Genet. 20, 675–691 (2019).
Article CAS PubMed Google Scholar
Liu, C. X. & Chen, L. L. Circular RNAs: characterization, cellular roles, and applications. Cell 185, 2016–2034 (2022).
Article CAS PubMed Google Scholar
Jeck, W. R. et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19, 141–157 (2013).
Article CAS PubMed PubMed Central Google Scholar
Wesselhoeft, R. A., Kowalski, P. S. & Anderson, D. G. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat. Commun. 9, 2629 (2018). This study optimizes PIE circRNA synthesis and uses exogenous circRNAs for robust and stable protein expression in eukaryotic cells, showing that circRNA is a promising alternative to linear mRNA.
Article PubMed PubMed Central Google Scholar
Piwecka, M. et al. Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science 357, eaam8526 (2017).
Hansen, T. B. et al. miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J. 30, 4414–4422 (2011).
Article CAS PubMed PubMed Central Google Scholar
Lebreton, A., Tomecki, R., Dziembowski, A. & Séraphin, B. Endonucleolytic RNA cleavage by a eukaryotic exosome. Nature 456, 993–996 (2008).
Article CAS PubMed Google Scholar
Liu, C. X. et al. Structure and degradation of circular RNAs regulate PKR activation in innate immunity. Cell 177, 865–880.e21 (2019).
Article CAS PubMed Google Scholar
Unti, M. J. & Jaffrey, S. R. Highly efficient cellular expression of circular mRNA enables prolonged protein expression. Cell Chem. Biol. 31, 163–176.e5 (2024).
Article CAS PubMed Google Scholar
Tai, J. & Chen, Y. G. Differences in the immunogenicity of engineered circular RNAs. J. Mol. Cell Biol. 15, mjad002 (2023). A review article providing a detailed discussion of the immunogenicity of IVT-derived circRNA.
Article CAS PubMed PubMed Central Google Scholar
Chen, Y. G. et al. Sensing self and foreign circular RNAs by intron identity. Mol. Cell 67, 228–238.e5 (2017).
Article CAS PubMed PubMed Central Google Scholar
Chen, Y. G. et al. N6-methyladenosine modification controls circular RNA immunity. Mol. Cell 76, 96–109.e9 (2019).
Article CAS PubMed PubMed Central Google Scholar
Wesselhoeft, R. A. et al. RNA circularization diminishes immunogenicity and can extend translation duration in vivo. Mol. Cell 74, 508–520.e4 (2019). This study reports exogenous circRNA delivery and translation in vivo, showing that circRNA translation persists for longer than that of both unmodified and uridine-modified linear mRNAs.
Article CAS PubMed PubMed Central Google Scholar
Liu, C. X. et al. RNA circles with minimized immunogenicity as potent PKR inhibitors. Mol. Cell 82, 420–434.e6 (2022).
Article CAS PubMed Google Scholar
Guo, S. K. et al. Therapeutic application of circular RNA aptamers in a mouse model of psoriasis. Nat. Biotechnol. https://doi.org/10.1038/s41587-024-02204-4 (2024). This study shows that lipid nanoparticle-delivered double-stranded circRNAs can inhibit PKR activity, reduce inflammatory signals and alleviate symptoms of psoriasis, highlighting their potential as a therapeutic strategy.
Chen, R. et al. Engineering circular RNA for enhanced protein production. Nat. Biotechnol. 41, 262–272 (2023). This study optimizes IVT circRNA design to markedly enhance protein production by improving key elements such as vector topology, untranslated regions and translation initiation factors.
Article CAS PubMed Google Scholar
Chen, H. et al. Chemical and topological design of multicapped mRNA and capped circular RNA to augment translation. Nat. Biotechnol. https://doi.org/10.1038/s41587-024-02393-y (2024).
Article PubMed PubMed Central Google Scholar
Xie, J. et al. Circular RNA: a promising new star of vaccine. J. Transl. Intern. Med. 11, 372–381 (2023).
Niu, D., Wu, Y. & Lian, J. Circular RNA vaccine in disease prevention and treatment. Signal Transduct. Target. Ther. 8, 341 (2023).
Article CAS PubMed PubMed Central Google Scholar
Qu, L. et al. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell 185, 1728–1744.e16 (2022). This study shows the successful use of IVT-derived circRNA for vaccination against SARS-CoV-2 in vivo.
Article CAS PubMed PubMed Central Google Scholar
Seephetdee, C. et al. A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera. Antivir. Res. 204, 105370 (2022).
Article CAS PubMed Google Scholar
Wan, J. et al. Circular RNA vaccines with long-term lymph node-targeting delivery stability after lyophilization induce potent and persistent immune responses. mBio 15, e0177523 (2024).
Li, H. et al. Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies. Theranostics 12, 6422–6436 (2022).
Article CAS PubMed PubMed Central Google Scholar
Yang, J. et al. Intratumoral delivered novel circular mRNA encoding cytokines for immune modulation and cancer therapy. Mol. Ther. Nucleic Acids 30, 184–197 (2022).
Article CAS PubMed PubMed Central Google Scholar
Feng, Z. et al. An in vitro-transcribed circular RNA targets the mitochondrial inner membrane cardiolipin to ablate EIF4G2+/PTBP1+ pan-adenocarcinoma. Nat. Cancer 5, 30–46 (2024).
Article CAS PubMed Google Scholar
Garber, K. Orna Therapeutics: circular logic. Nat. Biotechnol. https://doi.org/10.1038/d41587-022-00005-1 (2022).
留言 (0)